Instrument Inactif

Communiqués Intervacc AB (publ) Nasdaq Stockholm

Actions

SE0009607252

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Intervacc has presented new findings at the ACVIM Forum in the United States	13/06	AQ
Report from Annual General Meeting in Intervacc	15/05	AQ
Notice of Annual General Meeting in Intervacc AB (publ)	15/04	AQ
Intervacc publishes the 2023 Annual Report	10/04	AQ
Intervacc announces changes in the Nomination Committee	04/03	AQ
Jonas Sohlman appointed as new CEO for Intervacc	28/02	AQ
Intervacc announces changes in dates for AGM and report for the first quarter 2024	22/02	AQ
Year-end report January - December 2023	16/02	AQ
Invitation to conference call and audiocast in connection with the year-end report	13/02	AQ
Intervacc awarded prestigious Eurostars grant to advance their new prototype vaccine against Streptococcus suis infection in pigs	07/02	AQ
Intervacc announces changes in the Nomination Committee	21/12	AQ
The National Equestrian Centre at Flyinge to host European expert meeting on the use of vaccination to prevent strangles in horses	11/12	AQ
Report from Extraordinary General Meeting in Intervacc	23/11	AQ
U.S. patent approval for Intervacc's vaccine against infections caused by Streptococcus suis	22/11	AQ
Interim report January - September 2023	16/11	AQ
Invitation to conference call with presentation of Intervacc's Interim report for the third quarter, 2023	15/11	AQ
Nomination Committee appointed in Intervacc	30/10/23	AQ
NOTICE OF EXTRAORDINARY GENERAL MEETING IN INTERVACC AB (PUBL)	19/10/23	AQ
Intervacc : Agneta Gustafsson joins Intervacc	12/09/23	PU
Andreas Andersson steps down as President and CEO. Jonas Sohlman has been appointed acting President and CEO for Intervacc	21/08/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Intervacc AB (publ) Nasdaq Stockholm

Actions

SE0009607252

Communiqués

Filtres